Orchid Chemicals & Pharmaceuticals Ltd
Unaudited Financial Results for six months ended September 30, 2002
             
Sl No Particulars
Three Months Ended
30.09.2002
(Unaudited)
Three Months Ended
30.09.2001
(Unaudited)
SixMonths Ended
30.09.2002
(Unaudited)
Six Months Ended
30.09.2001
(Unaudited)
Year Ended 31.03.2002
(Audited)
1
 Sales and Operating Income
11133.26
9375.90
21816.76
18263.19
42552.48
2
 Other Income
28.27
35.64
30.87
37.58
75.32
3
 Total Expenditure
8914.33
7004.45
17392.04
13558.49
33365.74
a) Decrease/(Increase) in Stock in trade
(3320.34)
255.76
(3459.56)
130.50
(2266.84)
b) Consumption of raw materials
8109.01
3982.57
13679.55
8401.07
23514.95
c) Staff Cost
765.27
617.73
1518.69
1139.67
2506.10
d) Other Expenditure
3360.39
2148.39
5653.36
3887.25
9611.53
4
Profit before Interest, Depreciation & Tax (1+2-3)
2247.20
2407.09
4455.59**
4742.28
9262.06
5
Provision for doubtful debts
-
100.00
-
100.00
1195.43
6
 Interest and Finance Charges
1032.99
1008.73
1789.61
1797.77
3141.56
7
 Depreciation
867.98
852.12
1890.73
1676.47
3582.15
8
 Profit before tax (4-5-6-7)
346.23
446.24
775.25**
1168.04
1342.92
9
 Provision for Taxation
  -Current Tax
-
-
-
-
-
  -Deferred Tax
57.06
180.55
195.33
350.64
712.30
10
 Net Profit (8-9)
289.17
265.69
579.92**
817.40
630.62
11
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
2799.92
2799.92
2799.92
2799.92
2799.92
12
 Reserves excluding Revaluation Reserves
30137.32
13
 Basic & Diluted Earnings per Share (Rs.)
1.03*
1.97*
2.07*
2.92*
2.25
14 Aggregate of Non - Promoter Shareholding        
  -Number of equity shares of Rs.10/- each    
23413322
23325622
  -Percentage of Shareholding    
83.62
83.30
83.43
* EPS is for the period (not annualised)  
       
 
SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
Particulars
Three Months Ended
30-09-02
Three Months Ended
30-09-01
Six Months Ended
30-09-02
Six Months Ended
30-09-02
Year Ended
31-03-02
1. Segment Revenue        
a. Bulk
10279.32
9119.20
20004.05
17677.19
41273.30
b. Formulations
1452.25
590.40
2638.76
1057.26
2216.28
Total
11731.57
9709.60
22642.81
18734.45
43489.58
Less: Inter segment revenue
598.31
333.70
826.05
471.26
937.10
Net Sales / Income from Operations
11133.26
9375.90
21816.76
18263.19
42552.48
 
 
2. Segment Results
a. Bulk
1172.48
1582.77
2369.08
3242.12
5053.98
b. Formulations
179.04
(159.94)
165.48
(310.41)
(636.00)
Total
1351.52
1422.83
2534.56
2931.71
4417.98
Less:
i) Interest (Net)
1032.99
1008.73
1789.61
1797.77
3141.56
ii) Other unallocable expenditure net of unallocable income
(27.70)
(32.14)
(30.30)
(34.10)
(66.50)
Total Profit Before Tax
346.23
446.24
775.25
1168.04
1342.92
 
3. Capital Employed
a. Bulk
75540.53
86052.60
75540.53
86052.60
73590.02
b. Formulations
4202.84
(2287.74)
4202.84
(2287.74)
2786.11
Total
79743.37
83764.86
79743.37
83764.86
76376.13
 
  • The above financial results were adopted by the Board of Directors at its meeting held on Tuesday, October 29, 2002.
  • Previous period figures have been regrouped wherever necessary.
  • **The Company has decided for an early implementation of Accounting Standard 26 (Intangible Assets) issued by the Institute of Chartered Accountants of India. Accordingly, the financial results for the half year of this fiscal have been prepared in line with the new Accounting Standard AS-26. Due to the early implementation of AS-26, the profits for the first half of this fiscal are lower by Rs.334.26 lakhs. Further, in line with the said standard, the deferred revenue expenditure of Rs.2970.53 lakhs which includes amongst others, Research & Development, Product Registration and Development expenses outstanding as at March 31, 2002 has been set off against the reserves. The opening reserves now stand at Rs.27166.79 lakhs.

Place : Chennai
Date : 29-10-2002

For and on behalf of the Board

K.Raghavendra Rao
Managing Director